Life News Hub

Integration of clinical, pathological, radiological, and transcriptomic data improves prediction for first-line immunotherapy outcome in metastatic non-small cell lung cancer.

From Physician's Weekly

Integration of clinical, pathological, radiological, and transcriptomic data improves prediction for first-line immunotherapy outcome in metastatic non-small cell lung cancer.

CBIO-center for Computational Biology, MINES ParisTech, PSL Research University, Paris, France.

Laboratoire d'Imagerie Translationnelle en Oncologie, Institut Curie, Inserm U1288, PSL Research University, Orsay, France.

Narinée Hovhannisyan-Baghdasarian

Laboratoire d'Imagerie Translationnelle en Oncologie, Institut Curie, Inserm U1288, PSL Research University, Orsay, France.

Institut du Thorax Curie-Montsouris, Institut Curie, Paris, France.

Paulette Salamoun Feghali

Institut du Thorax Curie-Montsouris, Institut Curie, Paris, France.

Christine Lonjou

Bioinformatics and computational systems biology of cancer, Institut Curie, Inserm U900, PSL Research University, Paris, France.

Clément Beaulaton

Department of pathology, Institut Curie, Paris, France.

Immunity and cancer, Institut Curie, Inserm U932, PSL Research University, Paris, France.

Laboratoire d'Imagerie Translationnelle en Oncologie, Institut Curie, Inserm U1288, PSL Research University, Orsay, France.

Nicolas Girard

Institut du Thorax Curie-Montsouris, Institut Curie, Paris, France.

Emmanuel Barillot

Bioinformatics and computational systems biology of cancer, Institut Curie, Inserm U900, PSL Research University, Paris, France. [email protected].

Previous articleNext article

POPULAR CATEGORY

entertainment

11627

discovery

5219

multipurpose

12236

athletics

12395